Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Squamous Cell Carcinoma of Head and Neck × Sirolimus × 90 days × Clear all

Sponsor

Conditions

Hematologic Neoplasms 6 Precursor Cell Lymphoblastic Leukemia-Lymphoma 4 Lymphoma 4 Leukemia, Myeloid, Acute 4 Rhabdomyosarcoma 3 Neoplasms 3 Sarcoma, Ewing 2 Sarcoma 2 Rhabdoid Tumor 2 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2 Neuroblastoma 2 Neoplasms, Germ Cell and Embryonal 2 Myelodysplastic Syndromes 2 Melanoma 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Bronchiolitis Obliterans Syndrome 2 Brain Neoplasms 2 Wilms Tumor 1 Waldenstrom Macroglobulinemia 1 Tufted angioma 1 Tuberous Sclerosis 1 Thrombocytopenia 1 Skin Neoplasms 1 Rhabdomyosarcoma, Embryonal 1 Rhabdomyosarcoma, Alveolar 1 Refractory Solid Tumors in Children 1 Recurrence 1 Pseudomyxoma Peritonei 1 Pinealoma 1 PRETEXT I Hepatoblastoma 1

Interventions

pembrolizumab 55 Cisplatin 35 Cetuximab 26 Carboplatin 24 Radiotherapy 18 Radiotherapy, Intensity-Modulated 17 Magnetic Resonance Spectroscopy 16 Specimen Handling 14 Paclitaxel 14 Nivolumab 14 Docetaxel 14 Platinum 8 Fluorouracil 8 1,2-diaminocyclohexaneplatinum II citrate 8 Biopsy 6 (225)Ac-DOTA-c(RGDyK) 6 atezolizumab 5 Radiation 5 Ipilimumab 5 Drug Therapy 5 durvalumab 4 cemiplimab 4 Taxes 4 Standard of Care 4 Radiosurgery 4 Immunoglobulin G 4 Immune Checkpoint Inhibitors 4 Cyclophosphamide 4 Chemoradiotherapy 4 toripalimab 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡